October 2020 updates to the website
14 October 2020
The website has now been updated following October's LSCMMG
The following guidelines have been added/updated:
Antipsychotic - shared care guidance – update
The following Items will be ratified and added to the website following Joint Committee of CCGs (JCCCG) Meeting:
Dibotermin alfa (InductOs®) - for the treatment of acute tibia Gustilo-Anderson grade IIIB fractures in adults, as an adjunct to standard care using open fracture reduction and intramedullary unreamed nail fixation (licensed indication)
Dibotermin alfa (InductOs®) - for use outside of the licensed indication for the treatment of non-union long bone fractures
Rifaximin - Second line antibacterial treatment for the treatment of Small Intestinal Bacterial Overgrowth
Linezolid - Pneumonia, skin and soft-tissue infections
Vaco Cast Diabetic - Pneumonia, skin and soft-tissue infections
Psoriasis: LSCMMG Biologic and High Cost Drug Commissioning Pathway - Update
Over the Counter Items that Should not be Routinely Prescribed in Primary Care Policy - Update
Pneumococcal and Haemophilus type b / Meningococcal (Menitorix) group C Vaccines - Use in adults with low antibody levels
Melatonin - Melatonin Prolonged Release Tablets (Circadin®) for the Treatment of Rapid Eye Movement (REM) Sleep Behaviour Disorder (RBD) in Parkinson’s Disease
Linezolid - Pneumonia, skin and soft-tissue infections
Pregabalin - Treatment of GAD
Domperidone - As a galactagogue for birth mothers and mothers of adopted babies
Oscillating Positive Expiratory Pressure Devices - For Non – Cystic Fibrosis Bronchiectasis